Last reviewed · How we verify
NCT05394324
A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products
trial testing Intervention in Refractive Error in 1,674 participants. Completed in 31 May 2025.
31 May 2025
Quick facts
| Lead sponsor | Johnson & Johnson Surgical Vision, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,674 |
| Start date | 21 June 2022 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 May 2025 |
| Sites | 13 locations across United States, Germany, Spain |
Drugs / interventions tested
- Intervention
Conditions studied
- Refractive Error — all drugs for Refractive Error →
- Glaucoma — all drugs for Glaucoma →
- Cataracts — all drugs for Cataracts →
- Clear Lens Exchange — all drugs for Clear Lens Exchange →
Sponsor
Johnson & Johnson Surgical Vision, Inc. — full company profile →
Who can join
Eligibility, any sex, with Refractive Error or Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05394324
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intervention
Trials testing the same drug.
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT06112431 — Eye Health Intervention Study in Upper Manhattan · NA · not yet recruiting
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica · NA · enrolling by invitation
- NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery · NA · not yet recruiting
Other recruiting trials for Refractive Error
Currently open trials in the same condition.
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
Other Johnson & Johnson Surgical Vision, Inc. trials
Trials by the same sponsor.
- NCT07324200 — Objective Assessment of Intraocular Lens Tilt and Decentration · recruiting
- NCT07218419 — Comparison of Methods for Assessing Intraocular Lens Position · completed
- NCT06797856 — Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer · completed
- NCT05090787 — Clinical Investigation of the TECNIS 1-Piece Intraocular Lens · NA · withdrawn
- NCT06767319 — Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05394324 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Surgical Vision, Inc.
- Last refreshed: 20 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05394324.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing